FD2056
FD2056 is a potent and orally bioavailable pan-PI3K inhibitor with additional activity against CDK2/4. It demonstrates robust anti-proliferative and pro-apoptotic effects in breast cancer cell lines and has shown efficacy in suppressing tumor growth in vivo, making it a valuable tool for oncology research.
Product Specifications
CAS Number
2685870-87-3
Field of Research
Signal Transduction
Smiles
NC1=CC (C=2C=3C (NC2) =NC=C (C3) C=4C=C (NS (=O) (=O) C5=CC=CC=C5) C (Cl) =NC4) =CC=N1
Molecular Formula
C23H17ClN6O2S
Molecular Weight
476.94
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
036384-PE 200 µL
GUCA2B, CT (GUCA2B, Guanylate cyclase activator 2B, Guanylate cyclase C-activating peptide 2, Guanylate cyclase C-activating peptide II, Uroguanylin) (PE) discontinued
Sign In for Pricing
View Details 
LS029915 100 µg
Host cell factor C2 (HCFC2) (NM_013320) Human Over-expression Lysate
Sign In for Pricing
View Details 148962 100 µg
RASSF3, Control Peptide (Ras Association Domain-containing Protein 3, MGC119194, MGC119195, MGC119197, RASSF5)
Sign In for Pricing
View Details